Rejuvenation with PRF

Investigation the effect of platelet Rich fibrin matrix in correction of periorbital wrinkles

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220218054054N1

Enrollment

Registered

2022-03-12

Start date

2022-03-08

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

face aging.

Interventions

Intervention group:At first photography will be taken by Visioface 1000 D (CK electronic, manufactured in Germany) and after PRF injection (3month) photography will be taken again..

Eligibility

Sex/Gender

All

Age

30 Years to No maximum

Inclusion criteria

Inclusion criteria: Any adult over 30 with facial wrinkles

Exclusion criteria

Exclusion criteria: History of anticoagulant Administration such as warfarin and ASA History of immunomodulatory medications History of a medical problem such as connective tissue disorders Pregnancy

Design outcomes

Primary

Measure	Time frame
Skin facial aging. Timepoint: Prior and 12 weeks after PRF injection. Method of measurement: visioface device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRazieh Ahmadi Mahmoodabadi

Shiraz University of Medical Sciences

dr.ahmadirazieh@gmail.com+98 71 3212 5239

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026